Search Results1-9 of  9

  • Iwanaga Shin-ichiro ID: 9000009564434

    Articles in CiNii:1

    • Effect of Additives in ArF Single Layer Chemical Amplification Photoresist (1996)
  • IWANAGA SHIN-ICHIRO ID: 9000252776918

    Electronic Material Laboratory, Yokkaichi Research Laboratories Japan Synthetic Rubber Co., Ltd. (1996 from CiNii)

    Articles in CiNii:1

    • Effect of Additives in ArF Single Layer Chemical Amplification Photoresist. (1996)
  • IWANAGA Shin-ichiro ID: 9000006072365

    Research Director, Fine Electric Research Laboratories, Yokkaichi Research Center, JSR Corporation (2006 from CiNii)

    Articles in CiNii:1

    • Properties of Epoxy-Phenol Thermosetting Resin Using New Modified Styrene Butadiene Rubber (2006)
  • IWANAGA Shin-ichiro ID: 9000014255116

    JSR Corporation (1998 from CiNii)

    Articles in CiNii:1

    • Current Status of ArF Single Layer Resist Material and Its Future Forecast (1998)
  • IWANAGA Shin-ichiro ID: 9000256074675

    Fine Electric Research Laboratories, Yokkaichi Research Center, JSR Corporation (2006 from CiNii)

    Articles in CiNii:1

    • Properties of Epoxy-Phenol Thermosetting Resin Using New Modified Styrene Butadiene Rubber (2006)
  • Iwanaga Shin-ichiro ID: 9000258390742

    JSR Corporation (2005 from CiNii)

    Articles in CiNii:1

    • Low Elastic Modulus Epoxy Compound using styrene-butadiene rubber particles (2005)
  • Iwanaga Ichiro ID: 9000239881429

    Articles in CiNii:1

    • Phase II study of combined chemotherapy with irinotecan and S-1 (IRIS) plus bevacizumab in patients with inoperable recurrent or advanced colorectal cancer (2012)
  • Iwanaga Ichiro ID: 9000303992608

    Articles in CiNii:1

    • Open-label, randomized, comparative, phase III study on effects of reducing steroid use in combination with Palonosetron (2015)
  • Iwanaga Ichiro ID: 9000381958661

    Articles in CiNii:1

    • Study protocol of HGCSG1404 SNOW study : a phase I/II trial of combined chemotherapy of S-1, nab-paclitaxel and oxaliplatin administered biweekly to patients with advanced gastric cancer (2017)
Page Top